Our Blog Melanoma360

Blog - Melanoma360

Featured image for “Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma”
11/24/2020

Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
Blog - Melanoma360
Breaking News
Melanoma Research
Featured image for “Donor Spotlight: Gina Roller”
11/24/2020

Donor Spotlight: Gina Roller

Friendship is Forever By Mara Klecker Gina Roller’s best friend, Kerri-Lynn Larimer, adopted and lived by the motto “crazy not…
Blog - Melanoma360
Friends, Family, & Caregivers
Philanthropy
Featured image for “Melanoma by the State: North Dakota”
11/12/2020

Melanoma by the State: North Dakota

North Dakota Wants Residents to Protect Their Skin North Dakota is a farming and ranching state, with 39.1 million acres…
Blog - Melanoma360
Melanoma by the State
Featured image for “President’s Letter | November 2020”
11/12/2020

President’s Letter | November 2020

From the Desk of Samantha Guild It’s hard to believe that we’re nearing the holiday season and the end of…
Blog - Melanoma360
President's Letter
Featured image for “Survivor Spotlight: Stephanie Bowen, Stage IV Survivor”
11/12/2020

Survivor Spotlight: Stephanie Bowen, Stage IV Survivor

A Woman of Determination By Mara Klecker The second diagnosis came just days before Christmas 2010, almost exactly a decade…
Blog - Melanoma360
Survivor Stories
Featured image for “Survivor Spotlight: Tom Lauritzen, Stage III Survivor”
11/12/2020

Survivor Spotlight: Tom Lauritzen, Stage III Survivor

On the Road Again…Soon By, Alicia Rowell Tom Lauritzen has lived his whole life in Pittsburgh, Pennsylvania, save for a…
Blog - Melanoma360
Survivor Stories
Featured image for “In Plain English—Neo-Adjuvant Therapy for Palpable/Resectable Stage III Melanoma”
11/12/2020

In Plain English—Neo-Adjuvant Therapy for Palpable/Resectable Stage III Melanoma

  By Kim Margolin, M.D. In this chapter of “In Plain English,” we will describe the concept of neo-adjuvant therapy. Certain terms…
Blog - Melanoma360
In Plain English
Featured image for “Have You Checked Out Our New Website?”
09/29/2020

Have You Checked Out Our New Website?

AIM announced the launch of our redesigned website last week. Have you had an opportunity to take a look? Every…
Blog - Melanoma360
Featured image for “President’s Letter |September 2020”
09/29/2020

President’s Letter |September 2020

From the Desk of Samantha Guild The fall is upon us, and here at AIM at Melanoma, we’re busy with…
Blog - Melanoma360
President's Letter
Featured image for “Joe Small: Stage III Survivor Spotlight”
09/29/2020

Joe Small: Stage III Survivor Spotlight

By, Alicia Rowell It was 2016—October, specifically—when Joe Small showed a little spot on his right forearm to his doctor…
Blog - Melanoma360
Survivor Stories
11/24/2020

Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma

Published: Nov 23, 2020 By Mark Terry in BIOSPACE Immunocore, based in Oxfordshire, England, Conshohocken, Pennsylvania and Rockville, Maryland, announced that its Phase…
Featured image for “Immunocore’s Tebentafusp Successfully Activates T Cells Against Uveal Melanoma”
Blog - Melanoma360
 | 
Breaking News
 | 
Melanoma Research
11/24/2020

Donor Spotlight: Gina Roller

Friendship is Forever By Mara Klecker Gina Roller’s best friend, Kerri-Lynn Larimer, adopted and lived by the motto “crazy not…
Featured image for “Donor Spotlight: Gina Roller”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy
11/12/2020

Melanoma by the State: North Dakota

North Dakota Wants Residents to Protect Their Skin North Dakota is a farming and ranching state, with 39.1 million acres…
Featured image for “Melanoma by the State: North Dakota”
Blog - Melanoma360
 | 
Melanoma by the State
11/12/2020

President’s Letter | November 2020

From the Desk of Samantha Guild It’s hard to believe that we’re nearing the holiday season and the end of…
Featured image for “President’s Letter | November 2020”
Blog - Melanoma360
 | 
President's Letter
11/12/2020

Survivor Spotlight: Stephanie Bowen, Stage IV Survivor

A Woman of Determination By Mara Klecker The second diagnosis came just days before Christmas 2010, almost exactly a decade…
Featured image for “Survivor Spotlight: Stephanie Bowen, Stage IV Survivor”
Blog - Melanoma360
 | 
Survivor Stories
11/12/2020

Survivor Spotlight: Tom Lauritzen, Stage III Survivor

On the Road Again…Soon By, Alicia Rowell Tom Lauritzen has lived his whole life in Pittsburgh, Pennsylvania, save for a…
Featured image for “Survivor Spotlight: Tom Lauritzen, Stage III Survivor”
Blog - Melanoma360
 | 
Survivor Stories
11/12/2020

In Plain English—Neo-Adjuvant Therapy for Palpable/Resectable Stage III Melanoma

  By Kim Margolin, M.D. In this chapter of “In Plain English,” we will describe the concept of neo-adjuvant therapy. Certain terms…
Featured image for “In Plain English—Neo-Adjuvant Therapy for Palpable/Resectable Stage III Melanoma”
Blog - Melanoma360
 | 
In Plain English
09/29/2020

Have You Checked Out Our New Website?

AIM announced the launch of our redesigned website last week. Have you had an opportunity to take a look? Every…
Featured image for “Have You Checked Out Our New Website?”
Blog - Melanoma360
09/29/2020

President’s Letter |September 2020

From the Desk of Samantha Guild The fall is upon us, and here at AIM at Melanoma, we’re busy with…
Featured image for “President’s Letter |September 2020”
Blog - Melanoma360
 | 
President's Letter
09/29/2020

Joe Small: Stage III Survivor Spotlight

By, Alicia Rowell It was 2016—October, specifically—when Joe Small showed a little spot on his right forearm to his doctor…
Featured image for “Joe Small: Stage III Survivor Spotlight”
Blog - Melanoma360
 | 
Survivor Stories